Global Topical Corticosteroids Market Size, Share, Forecast Report, 2020-2027

Corticosteroids are synthetic analogues of the natural hormones produced by the adrenal cortex. Topical corticosteroids are hydrocortisone-derivative compounds with differentiated anti-inflammatory potency. They are used to treat many inflammatory skin diseases such as contact curative, insect stings topical corticosteroids.

Increasing prevalence of skin diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population, and growing number of skin disorders cases in children boost the growth of the market.

On the other hand, the price of the topical corticosteroids and their side effects may hamper the market growth during the corresponding period.

The global topical corticosteroids market is expected to grow at a CAGR of ~5.8% during the forecast period 2017-2023.
Segments
The global topical corticosteroids market is segmented on the basis of type of formulation, which is segmented into ointments, creams, and others.

On the basis of type of potency class, it is segmented into ultra-high, high, moderate, and low. The ultra high is further segmented into clobetasol propionate and diflorasone diacetate. The high segment is further segmented into amcinonide, betamethasone dipropionate, desoximetasone, fluocinonide, halcinonide, and others. The moderate segment is further segmented into desoximetasone, fluocinolone acetonide, fludroxycortide, hydrocortisone valerate, triamcinolone acetonide, and others. And the low segment is further segmented into betamethasone valerate, desonide, fluocinolone acetonide, and others.

On the basis of treatment, it is segmented into contact dermatitis, insect stings, psoriasis, eczema, and others.

On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.
Key Players in the Global Topical Corticosteroids Market

Some of the key players in this market are AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Actimis Pharmaceuticals, Valeant Pharmaceuticals, Almirall, S.A, and Zylera Pharmaceuticals.